OurPharma is a new drug company created to address the need for medications that are in short supply regionally and nationally. The initial focus will be on sterile-to-sterile compounding of injectables and intravenous fluids needed by hospitals, surgery centers and clinics. The founding team anticipates continued growth into manufacturing of medications such as insulin in the future. The OurPharma founders have an extensive background in hospital and healthcare administration, giving them firsthand knowledge of the difficulties caused by drug shortages and the effects on patients.
STERILE COMPOUNDED PRODUCTS
Pain Control Devices
OurPharma Groundbreaking Ceremony
Progression through November 2018
OurPharma will produce critical, high-quality medications that are essential to the health and well-being of our patients.
Peter Kohler, CEO